Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin+Sitagliptin”

167 trials

Showing 20 of 167 results

Post-approval studies (Phase 4)Study completedNCT05167513
What this trial is testing

Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients

Who this might be right for
Quality of LifeType 2 DiabetesMetformin+Sitagliptin
Getz Pharma 188
Post-approval studies (Phase 4)Study completedNCT01398592
What this trial is testing

Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy

Who this might be right for
Diabetes Mellitus Type 2
Novartis Pharmaceuticals 187
Large-scale testing (Phase 3)Ended earlyNCT01549964
What this trial is testing

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

Who this might be right for
Glycemic Control
Takeda 916
Large-scale testing (Phase 3)Study completedNCT01529541
What this trial is testing

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone

Who this might be right for
Type 2 Diabetes Mellitus
JW Pharmaceutical 200
Post-approval studies (Phase 4)UnknownNCT01895569
What this trial is testing

Triple Therapy in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
University of Pavia 64
Large-scale testing (Phase 3)Study completedNCT00363948
What this trial is testing

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ono Pharmaceutical Co., Ltd. 188
Early research (Phase 1)Study completedNCT00961857
What this trial is testing

Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 48
Large-scale testing (Phase 3)Study completedNCT00976937
What this trial is testing

24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 319
Early research (Phase 1)Study completedNCT01093794
What this trial is testing

Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 28
Large-scale testing (Phase 3)Study completedNCT01076075
What this trial is testing

Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 427
Large-scale testing (Phase 3)Study completedNCT03125694
What this trial is testing

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

Who this might be right for
Uncontrolled Type 2 Diabetes Mellitus
Tehran University of Medical Sciences 250
Not applicableUnknownNCT05214235
What this trial is testing

A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients

Who this might be right for
Diabetes MellitusSpinal Diseases
Xijing Hospital 124
Post-approval studies (Phase 4)Study completedNCT04916093
What this trial is testing

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Beni-Suef University 60
Not applicableStudy completedNCT07763951
What this trial is testing

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.

Who this might be right for
Bioequivalance
ADIUM 46
Post-approval studies (Phase 4)UnknownNCT00699322
What this trial is testing

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 36
Large-scale testing (Phase 3)Study completedNCT00484419
What this trial is testing

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

Who this might be right for
Type 2 DiabetesHyperlipidemia
Daiichi Sankyo 169
Post-approval studies (Phase 4)Study completedNCT01193296
What this trial is testing

Glycemic Holter Study (Continuous Glucose Monitoring) -

Who this might be right for
Type 2 Diabetes Mellitus
Novartis 36
Large-scale testing (Phase 3)Study completedNCT01076088
What this trial is testing

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 744
Post-approval studies (Phase 4)Study completedNCT07531108
What this trial is testing

Effects of Empagliflozin-Metformin, Sitagliptin-Metformin, and Metformin on Adipokines in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Hawler Medical University 186
Large-scale testing (Phase 3)Study completedNCT02623998
What this trial is testing

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

Who this might be right for
Type 2 Diabetes Mellitus
Population Health Research Institute 102
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation